UA75060C2 - Substituted n-benzyl-indole-3-yl-glyoxylic acid derivatives having antitumor activity, use thereof and pharmaceutical composition based thereon - Google Patents

Substituted n-benzyl-indole-3-yl-glyoxylic acid derivatives having antitumor activity, use thereof and pharmaceutical composition based thereon Download PDF

Info

Publication number
UA75060C2
UA75060C2 UA2002076107A UA2002076107A UA75060C2 UA 75060 C2 UA75060 C2 UA 75060C2 UA 2002076107 A UA2002076107 A UA 2002076107A UA 2002076107 A UA2002076107 A UA 2002076107A UA 75060 C2 UA75060 C2 UA 75060C2
Authority
UA
Ukraine
Prior art keywords
acid
group
alkyl
substituted
cooh
Prior art date
Application number
UA2002076107A
Other languages
English (en)
Ukrainian (uk)
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of UA75060C2 publication Critical patent/UA75060C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
UA2002076107A 1999-12-23 2000-12-19 Substituted n-benzyl-indole-3-yl-glyoxylic acid derivatives having antitumor activity, use thereof and pharmaceutical composition based thereon UA75060C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19962300A DE19962300A1 (de) 1999-12-23 1999-12-23 Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
PCT/EP2000/012947 WO2001047913A2 (de) 1999-12-23 2000-12-19 Substituierte n-benzyl-indol-3-yl- glyoxylsäure-derivate antitumorwirkung

Publications (1)

Publication Number Publication Date
UA75060C2 true UA75060C2 (en) 2006-03-15

Family

ID=7934006

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2002076107A UA75060C2 (en) 1999-12-23 2000-12-19 Substituted n-benzyl-indole-3-yl-glyoxylic acid derivatives having antitumor activity, use thereof and pharmaceutical composition based thereon

Country Status (31)

Country Link
US (1) US6432987B2 (cs)
EP (1) EP1240157B1 (cs)
JP (1) JP2003519137A (cs)
KR (1) KR100747425B1 (cs)
CN (1) CN1283637C (cs)
AR (1) AR027098A1 (cs)
AT (1) ATE259364T1 (cs)
AU (1) AU772745B2 (cs)
BG (1) BG106924A (cs)
BR (1) BR0016712A (cs)
CA (1) CA2395259A1 (cs)
CO (1) CO5251472A1 (cs)
CZ (1) CZ20022094A3 (cs)
DE (2) DE19962300A1 (cs)
DK (1) DK1240157T3 (cs)
ES (1) ES2215768T3 (cs)
HK (1) HK1054038B (cs)
HU (1) HUP0203716A3 (cs)
IL (1) IL150235A0 (cs)
MX (1) MXPA02006229A (cs)
NO (1) NO324750B1 (cs)
NZ (2) NZ533731A (cs)
PL (1) PL195014B1 (cs)
PT (1) PT1240157E (cs)
RU (1) RU2266280C2 (cs)
SK (1) SK8752002A3 (cs)
TR (1) TR200400601T4 (cs)
TW (1) TWI284128B (cs)
UA (1) UA75060C2 (cs)
WO (1) WO2001047913A2 (cs)
ZA (1) ZA200204896B (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814838C2 (de) * 1998-04-02 2001-01-18 Asta Medica Ag Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung
DE19946301A1 (de) * 1998-04-02 2001-04-19 Asta Medica Ag Indolyl-3-glyoxylsäure-Derivate mit therapeutisch wertvollen Eigenschaften
DE10037310A1 (de) * 2000-07-28 2002-02-07 Asta Medica Ag Neue Indolderivate und deren Verwendung als Arzneimittel
DE10318611A1 (de) * 2003-04-24 2004-11-11 Elbion Ag 4-, 6- oder 7-Hydroxyindole mit N-Oxidgruppen und deren Verwendung als Therapeutika
DE10318609A1 (de) * 2003-04-24 2004-11-11 Elbion Ag 5-Hydroxyindole mit N-Oxidgruppen und deren Verwendung als Therapeutika
RS20050901A (sr) * 2003-06-05 2007-12-31 Zentaris Gmbh., Derivati indola sa efektom na apoptozu
US7211588B2 (en) * 2003-07-25 2007-05-01 Zentaris Gmbh N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparation
MXPA06002853A (es) 2003-09-11 2006-06-14 Kemia Inc Inhibidores citoquina.
US7268159B2 (en) * 2003-09-25 2007-09-11 Wyeth Substituted indoles
DE102004031538A1 (de) * 2004-06-29 2006-02-09 Baxter International Inc., Deerfield Pharmazeutische Darreichungsform zur oralen Verabreichung eines schwerlöslichen Wirkstoffs, Verfahren zu deren Herstellung und Kit
DK1848430T3 (da) 2004-12-31 2017-11-06 Dr Reddys Laboratories Ltd Nye benzylamin-derivativer som cetp-inhibitors
US8604055B2 (en) 2004-12-31 2013-12-10 Dr. Reddy's Laboratories Ltd. Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
WO2006099256A2 (en) * 2005-03-11 2006-09-21 Vertex Pharmaceuticals Incorporated Modulators of atp-binding cassette transporters
EP2049520A4 (en) * 2006-08-07 2011-01-05 Ironwood Pharmaceuticals Inc indole compounds
AU2007325797B2 (en) * 2006-11-28 2014-03-13 Ziopharm Oncology, Inc. Use of indolyl-3-glyoxylic acid derivatives including indibulin, alone or in combination with further agents for treating cancer
NZ720946A (en) 2009-04-29 2017-09-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
AR084433A1 (es) 2010-12-22 2013-05-15 Ironwood Pharmaceuticals Inc Inhibidores de la faah y composiciones farmaceuticas que los contienen
CA2845284C (en) 2011-08-18 2018-03-06 Dr. Reddy's Laboratories Ltd. Substituted heterocyclic amine compounds as cholesteryl ester-transfer protein (cetp) inhibitors
JP6140168B2 (ja) 2011-09-27 2017-05-31 ドクター レディズ ラボラトリーズ リミテッド アテローム性動脈硬化症の処置のために有用なコレステリルエステル転送タンパク質（ｃｅｔｐ）インヒビターとしての５−ベンジルアミノメチル−６−アミノピラゾロ［３，４−ｂ］ピリジン誘導体

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1028812A (en) * 1962-08-28 1966-05-11 Ici Ltd Indole derivatives
US5496844A (en) * 1992-05-08 1996-03-05 Otsuka Pharmaceutical Factory, Inc. Indole derivatives
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors
EP0746544B1 (en) * 1994-02-22 1998-09-09 Merrell Pharmaceuticals Inc. Novel indole derivatives useful to treat estrogen-related neoplasms and disorders
JP3109974B2 (ja) * 1994-04-01 2000-11-20 イーライ・リリー・アンド・カンパニー １Ｈ−インドール−３−グリオキシルアミドｓＰＬＡ２阻害剤
DE19636150A1 (de) * 1996-09-06 1998-03-12 Asta Medica Ag N-substituierte Indol-3-glyoxylamide mit antiasthmatischer, antiallergischer und immunsuppressiver/immunmodulierender Wirkung
WO1998037069A1 (en) * 1997-02-20 1998-08-27 Shionogi & Co., Ltd. Indole dicarboxylic acid derivatives
US5972988A (en) * 1997-03-26 1999-10-26 Eli Lilly And Company Method for treatment of chronic bronchitis using indole compounds
WO1998047507A1 (en) * 1997-04-24 1998-10-29 Shionogi & Co., Ltd. Method for the treatment of stroke using n-heterocyclic glyoxylamide compounds
TW455581B (en) * 1997-06-26 2001-09-21 Lilly Co Eli Process for preparing 4-substituted-1H-indole-3-glyoxamides
CA2301586A1 (en) * 1997-08-28 1999-03-04 William Louis Macias Method for treatment of non-rheumatoid arthritis
CA2304482A1 (en) * 1997-09-26 1999-04-08 Eli Lilly And Company Method for the treatment of cystic fibrosis
JP2001520998A (ja) * 1997-10-27 2001-11-06 イーライ・リリー・アンド・カンパニー インドールｓＰＬＡ２阻害剤のモルホリノ−Ｎ−エチルエステルプロドラッグ
CA2309135A1 (en) * 1997-10-27 1999-05-06 Michael Lyle Denney N,n-diethylglycolamido ester prodrugs of indole spla2 inhibitors
WO1999021545A1 (en) * 1997-10-27 1999-05-06 Eli Lilly And Company ISOPROPYL ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS
WO1999024033A1 (en) * 1997-11-12 1999-05-20 Shionogi & Co., Ltd. Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds
WO1999025339A1 (en) * 1997-11-14 1999-05-27 Eli Lilly And Company Treatment for alzheimer's disease
PL343007A1 (en) * 1998-02-25 2001-07-30 Genetics Inst Inhibitors of phospholipase enzymes
DE19814838C2 (de) * 1998-04-02 2001-01-18 Asta Medica Ag Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung
DZ2770A1 (fr) * 1998-04-17 2003-12-01 Lilly Co Eli Procédé de préparation de 1h-indol-3 glyoxamides substituées en position 4.
DE59913617D1 (de) * 1998-04-28 2006-08-03 Elbion Ag Indolderivate und deren Verwendung als Inhibitoren der Phosphodiesterase 4.
DE19818964A1 (de) * 1998-04-28 1999-11-04 Dresden Arzneimittel Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phospodiesterase 4 und Verfahren zu deren Herstellung
CN1303290A (zh) * 1998-05-01 2001-07-11 伊莱利利公司 sPLA2抑制剂酯
TR200003194T2 (tr) * 1998-05-01 2001-03-21 Eli Lilly And Company Hastalık tedavisine mahsus sPLA2 önleyici bileşikler
WO2000067802A1 (en) * 1999-05-10 2000-11-16 Protarga, Inc. Fatty acid-n-substituted indol-3-glyoxyl-amide compositions and uses thereof
TWI269654B (en) * 1999-09-28 2007-01-01 Baxter Healthcare Sa N-substituted indole-3-glyoxylamide compounds having anti-tumor action

Also Published As

Publication number Publication date
EP1240157B1 (de) 2004-02-11
DE19962300A1 (de) 2001-06-28
DK1240157T3 (da) 2004-06-14
ZA200204896B (en) 2002-12-20
NZ519977A (en) 2004-08-27
IL150235A0 (en) 2002-12-01
EP1240157A2 (de) 2002-09-18
NO20023039L (no) 2002-08-09
HK1054038A1 (en) 2003-11-14
CN1420880A (zh) 2003-05-28
AU772745B2 (en) 2004-05-06
MXPA02006229A (es) 2003-01-28
SK8752002A3 (en) 2003-01-09
TR200400601T4 (tr) 2004-04-21
RU2002120462A (ru) 2004-01-10
HUP0203716A3 (en) 2004-05-28
HUP0203716A2 (hu) 2003-03-28
TWI284128B (en) 2007-07-21
PL355684A1 (en) 2004-05-17
CN1283637C (zh) 2006-11-08
NO20023039D0 (no) 2002-06-21
JP2003519137A (ja) 2003-06-17
KR100747425B1 (ko) 2007-08-09
PL195014B1 (pl) 2007-07-31
NO324750B1 (no) 2007-12-03
DE50005284D1 (de) 2004-03-18
CA2395259A1 (en) 2001-07-05
US6432987B2 (en) 2002-08-13
AU2011901A (en) 2001-07-09
BG106924A (bg) 2003-04-30
ATE259364T1 (de) 2004-02-15
US20010014690A1 (en) 2001-08-16
PT1240157E (pt) 2004-06-30
CO5251472A1 (es) 2003-02-28
WO2001047913A3 (de) 2002-04-25
WO2001047913A2 (de) 2001-07-05
AR027098A1 (es) 2003-03-12
BR0016712A (pt) 2002-09-03
KR20020063245A (ko) 2002-08-01
RU2266280C2 (ru) 2005-12-20
HK1054038B (zh) 2007-04-13
NZ533731A (en) 2005-03-24
CZ20022094A3 (cs) 2002-10-16
ES2215768T3 (es) 2004-10-16

Similar Documents

Publication Publication Date Title
US6207836B1 (en) Indolin-2-one derivatives
US6344467B1 (en) N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action
JP5253696B2 (ja) 抗腫瘍作用を有するインドリル−３−グリオキシル酸誘導体
AU768726B2 (en) Indole derivatives and their use for the treatment of osteoporosis amongst other applications
US6432987B2 (en) Substituted N-benzylindol-3-ylglyoxylic acid derivatives having antitumor action
UA100867C2 (uk) Похідна (аза)індолу, заміщена в положенні 5, фармацевтична композиція, що містить її, проміжні сполуки та спосіб їх одержання
CZ20003483A3 (cs) Deriváty indolyl-3-glyoxylové kyseliny s protinádorovým účinkem
MXPA00009646A (en) Indolyl-3-glyoxylic acid derivatives with antitumoral activity
HK1032953A1 (en) Indole derivatives useful a.o. for the treatment of osteoporosis